8-K: Scilex Holding Company Adjourns Annual Stockholder Meeting Due to Lack of Quorum, Reschedules for June 20

Scilex Holding Company has adjourned its 2025 Annual Meeting of Stockholders due to a lack of the required quorum, rescheduling the meeting for June 20, 2025, to allow more time for stockholder voting.

Summary

• Scilex Holding Company (SCLX) convened and subsequently adjourned its 2025 Annual Meeting of Stockholders on June 4, 2025.
• The adjournment was necessary due to a lack of the required quorum.
• The Annual Meeting will reconvene on June 20, 2025, at 9:00 a.m. Pacific Time.
• The reconvened meeting will be held via live audio webcast at www.virtualshareholdermeeting.com/SCLX2025.
• The purpose of the adjournment is to provide stockholders with additional time to vote on the proposals outlined in the definitive proxy statement filed on May 16, 2025.
• No changes have been made to the proposals to be voted on by stockholders.
• The record date for determining stockholder eligibility to vote remains May 15, 2025.
• Proxies previously submitted will be voted at the reconvened meeting unless properly revoked, and stockholders who have already voted do not need to take further action.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the adjournment of the annual meeting caused by a lack of quorum, which suggests potential issues with shareholder engagement or governance. While a new date is set, the initial failure is a drawback.

Negatives

• The 2025 Annual Meeting of Stockholders was adjourned due to a lack of the required quorum, indicating insufficient shareholder participation or engagement.
• The need to reconvene the meeting introduces a delay in corporate governance processes and decision-making.

Risks

• Lack of quorum at the annual meeting may signal low shareholder engagement or potential difficulties in obtaining shareholder approval for future proposals.
• Repeated issues with quorum could raise concerns about corporate governance effectiveness or investor confidence.

Future Outlook

The company's immediate future outlook involves successfully reconvening its 2025 Annual Meeting of Stockholders on June 20, 2025, to conduct the necessary business and vote on the previously disclosed proposals.

Management Comments

• The report was signed by Jaisim Shah, Chief Executive Officer and President of Scilex Holding Company, on June 4, 2025.

Industry Context

This announcement is a company-specific procedural event related to corporate governance and does not directly reflect broader industry trends or competitive dynamics within the pharmaceutical or biotech sectors. However, consistent issues with shareholder engagement, as indicated by a lack of quorum, could be viewed negatively by investors across any industry.

Corporate Governance

Stakeholder Impact

• Shareholders: Directly impacted by the delay in the annual meeting and the voting process. Those who have not yet voted are given additional time to do so.
• Management/Board: Faces the challenge of ensuring sufficient shareholder participation for the reconvened meeting to achieve a quorum and pass proposals.

Next Steps

• The 2025 Annual Meeting of Stockholders will reconvene on June 20, 2025, at 9:00 a.m. Pacific Time via live audio webcast.
• Stockholders who have not yet voted are encouraged to submit their proxies before the reconvened meeting.

Key Dates

Keywords

Scilex Holding Company, SCLX, Annual Meeting of Stockholders, Quorum, Adjournment, Proxy Statement, Corporate Governance, Shareholder Meeting, SEC Filing, 8-K